Republic Technologies Files Amended Interim Financial Statements and MD&A
As a result of a review by the British Columbia Securities Commission (the “BCSC”), we are issuing the following press release to clarify our disclosure.
Republic Technologies Inc. (CSE: DOCT) (FSE: 7FM0) (“Republic” or the “Company”) announces that, pursuant to Section 11.5 of National Instrument 51-102 - Continuous Disclosure Obligations, and as a result of a review by the BCSC, it has amended and refiled its interim financial statements and management’s discussion and analysis for the three and nine month period ended September 30, 2025 and 2024 (the “Amended Interim Financial Statements and MD&A”), in order to clarify its disclosure. The Amended Interim Financial Statements and MD&A provide revised updated disclosure related to, among other things, the Company's accounting for the convertible notes issued during the period, including the allocation of proceeds among the host debt, derivative and equity components, the valuation of the derivative liability and the measurement of the ETH-denominated note; the recognition of staking revenue; the measurement of the loss on the February 2025 debt settlement, including the portion settled with related parties; the presentation and classification of operating expenses and comparative balances; and its overall performance, results of operations, liquidity and capital resources, related party transactions and subsequent events. The Company also filed related officer’s certificates in connection with the filing of the Amended Interim Financial Statements and MD&A.
